Eledon Pharmaceuticals (ELDN) Assets (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.22% |
| Dec 31, 2025 | 30.15% |
| Sep 30, 2025 | -10.39% |
| Jun 30, 2025 | -10.17% |
| Mar 31, 2025 | -9.07% |
| Dec 31, 2024 | 54.84% |
| Sep 30, 2024 | -4.90% |
| Jun 30, 2024 | 49.08% |
| Mar 31, 2024 | -9.26% |
| Dec 31, 2023 | -7.29% |
| Sep 30, 2023 | -10.04% |
| Jun 30, 2023 | 29.74% |
| Mar 31, 2023 | -11.30% |
| Dec 31, 2022 | -37.97% |
| Sep 30, 2022 | -3.31% |
| Jun 30, 2022 | -4.13% |
| Mar 31, 2022 | -5.38% |
| Dec 31, 2021 | -3.74% |
| Sep 30, 2021 | -3.87% |
| Jun 30, 2021 | -3.85% |
| Mar 31, 2021 | -2.79% |
| Dec 31, 2020 | 2.39% |
| Sep 30, 2020 | 1,733.97% |
| Jun 30, 2020 | -23.46% |
| Mar 31, 2020 | 25.51% |
| Dec 31, 2019 | -28.17% |
| Sep 30, 2019 | -16.46% |
| Jun 30, 2019 | 35.42% |
| Mar 31, 2019 | -21.00% |
| Dec 31, 2018 | -14.56% |
| Sep 30, 2018 | -13.22% |
| Jun 30, 2018 | -11.39% |
| Mar 31, 2018 | 24.05% |
| Dec 31, 2017 | -9.24% |
| Sep 30, 2017 | -14.25% |
| Jun 30, 2017 | 3.92% |
| Mar 31, 2017 | 2,059.78% |
| Dec 31, 2016 | -96.74% |
| Sep 30, 2016 | -21.63% |
| Jun 30, 2016 | -18.81% |
| Mar 31, 2016 | -15.10% |
| Dec 31, 2015 | -12.41% |
| Sep 30, 2015 | -11.21% |
| Jun 30, 2015 | -9.56% |
| Mar 31, 2015 | -10.30% |
| Dec 31, 2014 | 0.71% |